No abstract available.
Amikacin* ; Cefuroxime* ; Hysterectomy* ; Sodium*

A randomized control clinical trial was carried out in National Obstetric and Gynecological Hospital in order to assess preventive effect of cefuroxime (Zinacef, made by Glaxo Smithline in India and England) from May to July, 2005. Results show that there was no difference about preventive effect between Indian cefuroxime and English cefuroxime. However, there was a big difference about cost between the two cefuroxime. English Zinacef had a double cost compared to Indian Zinacef. Indian Zinacef 750 mg had a good preventive effect with shorten course therapy, less hospitalization day and suitable cost
Preventive Medicine ; Cefuroxime ; Gynecologic Surgical Procedures ; Surgery

The efficacy of pre-operative single dose antimicrobial prophylaxis in preventing infection after gynecological surgery has been demonstrated. In this study 200 patients were randomly enrolled in two groups. Each of the 1st group (n=100) was received 2 g of ampicillin and 160 mg of gentamycin per day, during 7 days of postoperation. Each of the other (n=100) was received 1.5g of cefuroxime (Zinacef) single-dose 15-30 minutes before operation. The two treatments were compared. There was no difference between two groups about the number of white blood cell, the fever and the hospitalization stay. No infectious complication was noted. But in the group receiving Zinacef, the patient felt less painful and the hospitalization stay might be reduced
Cefuroxime ; Pharmaceutical Preparations ; surgery ; prevention ; infection

Antibiotic-loaded bone cement has been used as prophylaxis against infection in total joint replacement surgery. Its effect on the mechanical strength of cement is a major concern as high dose of antibiotic was associated with a significant reduction in mechanical strength of bone cement. However, the cut-off antibiotic that weakens the mechanical strength of cement remains to be determined. This study was undertaken to observe the changes in the mechanical properties of bone cement with gradual increments of Cefuroxime antibiotic. Cefuroxime at different doses: 0, 1.5, 3.0 and 4.5gm were added to a packet of 40gm bone cement (Simplex P) and study samples were prepared by using third generation cementing technique. Mechanical impact, flexural and tensile strength were tested on each sample. Significant impact and tensile strength reduction were observed after addition of 4.5 gm of Cefuroxime. However, flexural strength was significantly reduced at a lower dose of 3.0 gm. The maximum dose of Cefuroxime to be safely added to 40mg Surgical Simplex P is 1.5gm when third generation cementing technique is used. Further study is needed to determine whether it is an effective dose as regards to microbiological parameters.
Skeletal bone ; Cefuroxime ; Antibiotics ; meter ; Reduction (chemical)

Introduction: Chronic bullous disease of childhood (CBDC) is a rare immune-mediated subepidermal vesiculobullous eruption, characterized by linear IgA deposition along the basement membrane zone of the skin. Although mostly idiopathic, CBDC may be triggered by factors such as infection, and drugs. Clinical and immunohistopathological features of drug-induced cases are heterogeneous and indistinguishable from the idiopathic form. Case report: A two-year-old Filipino male presented with pruritic vesicles and bullae on the back several days after finishing a course of cefuroxime, and cefaclor. Examination revealed multiple tense vesicles and bullae, some coalescing into a rosette pattern with central crusts on the perioral, scalp, neck, back, perineal, and perianal areas. Histopathology showed a subepidermal split with neutrophilic and eosinophilic infiltrates. Direct immunofluorescence revealed strong linear deposition of IgA, and granular deposits of C3 and IgM at the basement membrane zone, thus confirming the di- agnosis of CBDC. Dapsone at 2mg/kg/day was started, with oral prednisolone (1.3mg/kg/day), and cloxacillin syrup (40mg/kg/day). Topical care with betamethasone dipropionate and mupirocin ointment was included. After eight weeks, patient showed significant im- provement with few vesicles and resolved lesions healing with post-inflammatory hyperpigmentation. Conclusion We report a case of a two-year-old male presenting with vesiculobullous lesions after a course of cefuroxime, and cefaclor. As both were given and withdrawn in a period of close proximity, it is difficult to determine the probable culprit drug. Spontaneous resolution upon withdrawal of the suspected drug is variable. Systemic therapy such as dapsone may be necessary for treatment.
Linear IgA Bullous Dermatosis ; Cefaclor ; Cefuroxime

PURPOSE: To evaluate an effect of controlled antibiotic release of the layered double hydroxides (LDH) as a new drug delivery system, and to observe a histological changes of the LDH in vivo and the differences of antibacterial effects among the several antibiotic-LDH hybrids. MATERIALS AND METHODS: Staphylococcus aureus (ATCC 23235) and Escherchia coli (ATCC 10536) were used as a bacterial specimens. Antibiotic-LDH hybrids were gentamicin-LDH (GM-LDH), cefaclor-LDH (CCLO-LDH), cefuroxime axetil-LDH (CRXMA-LDH) and ceftazidime-LDH (CAZ-LDH). In vitro study, two methods were used. One was dilution method, used to determine the minimum inhibitory concentrations (MICs) of the antibiotic-LDH hybrids. The other one was disk diffusion method, to observe the zones of bacterial inhibition of them. In vivo forty New Zealand White rabbits (2.5~3.0 kg) were divided into 10 groups. Animals were anesthetized and a 3 mm-diameter hole was drilled 2 cm proximal to the distal end of the left femur. The antibiotic-LDH hybrids was put into the drilled hole and then 0.1 ml (105 CFU/ml) of S. aureus and E. coli were inoculated into the drilled hole in each group. Histological examination was done at postoperative 1, 2, 3, and 4 weeks respectively. RESULTS: The MICs for S. aureus were more than 400 microgram/ml in GM-LDH, 25 microgram/ml in CRXMA-LDH, 25 microgram/ml in CCLO-LDH, and 100 microgram/ml in CAZ-LDH. The MICs for E. coli were 12.5 microgram/ml in GM-LDH, 25 microgram/ml in CRXMA-LDH, 25 microgram/ml in CCLO-LDH, and 1.56 microgram/ml in CAZ-LDH. CCLO-LDH was effective on both S. aureus and E. coli and CRXMA-LDH on E. coli in disk diffusion method. In contrast, GM-LDH and CAZ-LDH were not effective on neither S. aureus nor E. coli. Histologically, LDH was shown as large masses at the postoperative 1~2 weeks and changed to several small masses or fragments at the postoperative 3~4 weeks. CONCLUSION: There was much difference of the extent of controlled antibiotic release among antibiotic-LDH hybrids. The size and volume of LDH in vivo was reduced gradually. CCLO-LDH, and CRXMA-LDH seemed to have an effect of the bacterial growth inhibition.
Animals ; Cefuroxime ; Diffusion ; Drug Delivery Systems ; Femur ; Hydroxides ; Microbial Sensitivity Tests ; Rabbits ; Staphylococcus aureus

7-ACA(7-aminocephalosporanic acid) and ACT(aminocephalosporanic thiazine) are basic materials for development of 2nd and 3rd generation cephalosporin. Occupational asthmas(OA) induced by these materials have been very rarely reported. We had experienced 2 cases of OA by them. One was 26 year-old male laboratorian involving 7ACA manufacturing directly. The other case was 40 year-old male asthmatics working at the ware house keeping 7ACA and ACT, not directly making these. The result of skin prick test with 55 common inhalant allergens and 7ACA, ACT and several cephalosporins including Cefazolin, Cefuroxime, Ceftazidime, Cefotaxime, Ceftriaxone and Cefotetan. First case revealed positive reactions to 7ACA and Ceftriaxone, but second case, only positive to ACT. In first case, bronchial challenge with 7ACA only showed positive, but in second, those with 7ACA and ACT both showed positive, though negative to 7ACA in skin test.
Adult ; Allergens ; Asthma, Occupational* ; Cefazolin ; Cefotaxime ; Cefotetan ; Ceftazidime ; Ceftriaxone ; Cefuroxime ; Cephalosporins ; Humans ; Male ; Skin ; Skin Tests

BACKGROUND: It is traditiqnally considered that the non-bullous fonn of impetigo is primarily of streptococcal origin and the bullous form is of staphylococcal origin. However, recent reports have shown that Staphylococcus aureus (SA) has become the predominant cauative pathogen of non-bullous impetigo as well as of bullous impetigo. Objective. Our purpose was to evaluate the predominant causativi. pathogen, and to establish a therapeutic guideline for impetigo. METHOD: We described the characteristics of lesions and gerformed bacterial culture and susceptibility tests in patients with impetigo. Patients were treatecl by one of three frequently used antibiotics(erythromycin, cefuroxime, fusidic acid). RESULTS: Of 77 patients, there were 47 cases of crusted type(61.9%), 18 cases of mixed type with crusted and bullous lesiona(23.3%), 7 cases of mixed type with crusted and pustular lesions(9.1%) and 5 cases of bullous type(6.6%). SA was grown from 90.1% af the cases, in 83.1% of cases it was the only organism to be foind and no gowth of streptococcus was faund even in mixed infections. An antimicrobial susceptibility test of 63 strains of SA demonstrated high susceptibility to vancomycin(98.4%), cefuroxime(97.1%), oxacillin(96.4%), cephalothin(95.2%), fusidic acid(91.7%) etc, and high resistance to penicillin(93.7%), gentamicin(90.5%), tobramycin(88.9%) and erythromicin(80.9%). Of 19 patients treated with erythrornycin, 12(63.1% ) showed treatment failure at a weeks, while no treatment failure occured in groups treated with cefuroxime and usidic acid. There were statistically significant differences iri therapeutic effect between cefuroxirne and erythromycin(P=0.005 by two tailedy test), and betweer fusidic acid and erythromycin(P=0.0040. But there was no significant difference between cefuroxime and fusidic acid. CONCLUSION: The predominant pathogen of non-bullous impetigo a well as bullous impetigo was SA which were highly resistant to erythromycin and highly sensitive to efuroxime and fusidic acid. In the clinical response, cefuroxinie and fusidic acid treatment were most effective and erythromycin was inadequate for treatment of impetigo.
Cefuroxime ; Coinfection ; Erythromycin ; Furosemide ; Fusidic Acid ; Humans ; Impetigo* ; Staphylococcus aureus ; Streptococcus ; Treatment Failure

Cephalosporins are commonly used antibiotics in treatment of clinical infection. They frequently cause a positive direct antiglobulin test, but rarely cause hemolysis. The authors report a case of immune hemolytic anemia due to a second-generation cephalosporin, cefuroxime, by the drug adsorption mechanism.
Adsorption ; Anemia, Hemolytic* ; Anti-Bacterial Agents ; Cefuroxime* ; Cephalosporins ; Coombs Test ; Hemolysis

The aim of this study was to identify bacteria isolated from the oral cavities and to determine their antimicrobial susceptibility against eight antibiotics. The bacterial strains were obtained from the Korean Collection for Oral Microbiology (KCOM). The bacteria were identified by comparing 16S rDNA sequences at the species level. The data showed that 77 bacterial strains were predominantly identified as streptococci (49.4%) and staphylococci (14.3%). Minimum inhibitory concentrations (MIC) were determined using a broth dilution assay to test the sensitivity of the bacterial strains. The MIC values of the oral bacterial strains against antibiotics were different. Streptococci were sensitive to clindamycin, cefuroxime axetil, and vancomycin, and they were resistant to tetracycline. Staphylococci also were sensitive to clindamycin, cefuroxime axetil, and vancomycin, and they were resistant to penicillin antibiotics. Gram-negative bacterial strains were sensitive to tetracycline and were resistant to clindamycin. These results suggest that the antimicrobial susceptibility test is necessary in deciding the prescription for antibiotics, to prevent the misuse or abuse of antibiotics.
Anti-Bacterial Agents ; Bacteria* ; Cefuroxime ; Clindamycin ; DNA, Ribosomal ; Korea ; Microbial Sensitivity Tests ; Penicillins ; Prescriptions ; Tetracycline ; Vancomycin